News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
O'Dowd Hugh
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2022 |
4
| O'Dowd Hugh (CEO) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 2,125,000 restricted stock units
@ $0 |
|
| 08/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/11/2020 |
4
| O'Dowd Hugh (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.|
Txns:
| Granted 25,748 shares
@ $0 |
|
| 05/06/2020 |
4
| O'Dowd Hugh (President & CEO) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Disposed/sold 776,085 shares
@ $0
Disposed/sold 208,062 options to buy
@ $10.2, valued at
$2.1M
Disposed/sold 200,000 options to buy
@ $6.13, valued at
$1.2M
Disposed/sold 354,632 options to buy
@ $2.65, valued at
$939.8k
|
|
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2020 |
4
| O'Dowd Hugh (President & CEO) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 240,000 shares
@ $0 |
|
| 10/17/2019 |
4
| O'Dowd Hugh (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.|
Txns:
| Granted 85,201 options to buy
@ $6.79, valued at
$578.5k
|
|
| 10/17/2019 |
3
| O'Dowd Hugh (Director) has filed a Form 3 on PUMA BIOTECHNOLOGY, INC. |
| 03/01/2019 |
4
| O'Dowd Hugh (President & CEO) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 100,000 shares
@ $0
Granted 200,000 options to buy
@ $6.13, valued at
$1.2M
|
|
| 08/22/2018 |
4
| O'Dowd Hugh (President & CEO) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Exercised 18,868 options to buy
@ $2.65, valued at
$50k
|
|
| 06/26/2018 |
3
| O'Dowd Hugh (President & CEO) has filed a Form 3 on Neon Therapeutics, Inc. |
|
|